<DOC>
	<DOCNO>NCT01413685</DOCNO>
	<brief_summary>The purpose define calcineurin activity well biological parameter blood concentration therapeutic tacrolimus monitoring .</brief_summary>
	<brief_title>Calcineurin Activity Renal Recipients</brief_title>
	<detailed_description>Some author show determination calcineurin ( enzyme cyclosporin tacrolimus action ) activity interest bone narrow hepatic transplant order monitor tacrolimus cyclosporin . Indeed , Furthermore , target Tac concentration still fail provide certain patient appropriate immunosuppression reflect rejection . Because lack data renal transplant , propose study population treat tacrolimus , mycophenolate mofetil corticoid first three month follow transplantation . Our major aim study relationship calcineurin activity immunologic event 200 renal recipient treat tacrolimus first three month follow transplant . Immunologic event could acute rejection infraclinical rejection . The second aim 1 ) relationship exist , define threshold predict acute rejection use ROC-curve , 2 ) define variation pharmacodynamic ( calcineurin activity ) pharmacokinetic ( whole blood concentration ) tacrolimus monitor 3 ) compare calcineurin activity patient acute rejection borderline rejection . Blood sample collect EDTA-containing vacutainers prior tacrolimus morning administration 2 , 4 , 6 9 hour follow administration D7 , D14 D21 . Whole blood tacrolimus concentration calcineurin activity measure use LCMSMS HPLC technique . After D21 , residual measurement carry D28 , M2 M3 . A comparative statistical analysis perform data define without rejection . In case difference , ROC curve analysis could define normal range calcineurin activity . This second study Sud FRANCILIEN Institute Research Nephrology-Transplantation define Nephrology department Mondor BICETRE hospital object `` Interest pharmacodynamics immunosuppressive drug renal-transplant recipient '' new theme team .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>adult renal transplant recipient treat tacrolimus ( Prograf ADVAGRAF ) , corticoid , Cellcept , patient high risk bad compliance ( toxicomania , severe psychiatric trouble ) multiorgan transplant patient mTOR inhibitor treatment HIV infect patient lack consent study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>tacrolimus</keyword>
	<keyword>calcineurin</keyword>
	<keyword>pharmacodynamic</keyword>
	<keyword>TDM</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>